Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

ClinicalTrials.gov ID: NCT03170388

Public ClinicalTrials.gov record NCT03170388. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 8:14 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

Study identification

NCT ID
NCT03170388
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bausch Health Americas, Inc.
Industry
Enrollment
741 participants

Conditions and interventions

Conditions

Interventions

  • IDP-126 Gel Drug
  • IDP-126 Component A Drug
  • IDP-126 Component B Drug
  • IDP-126 Component C Drug
  • IDP-126 Vehicle Gel Drug

Drug

Eligibility (public fields only)

Age range
9 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 4, 2017
Primary completion
Apr 22, 2019
Completion
Apr 22, 2019
Last update posted
Nov 9, 2021

2017 – 2019

United States locations

U.S. sites
29
U.S. states
20
U.S. cities
27
Facility City State ZIP Site status
Valeant Site 02 Hot Springs Arkansas 71913
Valeant Site 07 Fremont California 94538
Valeant Site 08 Sacramento California 95819
Valeant Site 09 Denver Colorado 80220
Valeant Site 11 Boynton Beach Florida 33437
Valeant Site 13 North Miami Beach Florida 33162
Valeant Site 12 Sanford Florida 32771
Valeant Site 10 West Palm Beach Florida 33401
Valeant Site 15 Marietta Georgia 30060
Valeant Site 14 Snellville Georgia 30078
Valeant Site 16 Boise Idaho 83704
Valeant Site 17 Overland Park Kansas 66215
Valeant Site 18 Louisville Kentucky 40217
Valeant Site 19 Louisville Kentucky 40241
valeant Site 21 Glenn Dale Maryland 20769
Valeant Site 20 Needham Massachusetts 02492
Valeant Site 22 Detroit Michigan 48202
Valeant Site 24 Morristown New Jersey 07960
Valeant Site 25 Albuquerque New Mexico 87106
Valeant Site 27 New York New York 10022
Valeant Site 26 New York New York 10075
Valeant Site 23 High Point North Carolina 27262
Valeant Site 28 Gresham Oregon 97030
Valeant Site 30 Johnston Rhode Island 02919
Valeant Site 31 Nashville Tennessee 37215
Valeant Site 32 Austin Texas 78759
Valeant Site 33 Pflugerville Texas 78660
valeant Site 34 San Antonio Texas 78213
Valeant Site 35 Norfolk Virginia 23502

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03170388, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 9, 2021 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03170388 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →